Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

January 8, 2024

Study Completion Date

January 8, 2024

Conditions

Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG

Enzalutamide

enzalutamide treatment

Trial Locations (3)

CWZ, Nijmegen

Radboudumc, Nijmegen

Franciscus Gasthuis en Vlietland hospital, Rotterdam

All Listed Sponsors

lead

Radboud University Medical Center

OTHER

NCT03927391 - Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects | Biotech Hunter | Biotech Hunter